Autosomal Recessive Intermediate Charcot-Marie-Tooth Disease Type C (CMTRIC)

Autosomal recessive intermediate Charcot-Marie-Tooth disease type C (CMTRIC) is a very rare inherited nerve disease that mainly affects the long nerves in the arms and legs. It causes slowly worsening weakness and wasting of the small muscles of the feet, legs, hands and sometimes forearms, together with loss of feeling and reduced reflexes.GARD Information Center+2CAGS+2

Autosomal recessive intermediate Charcot-Marie-Tooth disease type C (often written as AR-CMT intermediate type C or CMTRIC) is a very rare inherited nerve disease. It mainly damages the long nerves that carry signals to and from the feet and hands. People usually develop problems from childhood to early adult life, with slowly worsening weakness, thin muscles in the feet and lower legs, high-arched feet, hammer toes and reduced feeling in the feet and sometimes hands. Nerve tests show “intermediate” speed, with features of both damaged myelin (the fatty coating of nerves) and damaged axons (the nerve core).Monarch Initiative+3Orpha+3Global Genes+3

How this disease affects the body

In autosomal recessive intermediate CMT type C, both copies of a gene related to peripheral nerves are changed (mutated). Because of this, the myelin sheath and the axon do not work normally. Over time, signals travel more slowly and become weaker. This causes weakness and wasting in the muscles that lift the foot and move the ankle, making the foot “slap” on the ground and the ankle turn easily. The body tries to adapt, and foot bones slowly change shape, leading to high arches and clawed toes. As the disease progresses, the same process can affect the hands and may cause balance problems due to loss of joint position sense.NCBI+2MalaCards+2

Doctors call it “intermediate” because nerve tests show speeds that are between the typical “slow” pattern seen in demyelinating CMT and the “normal-speed but weak signal” pattern seen in axonal CMT. In other words, both the insulating layer of the nerve (myelin) and the inner wire (axon) are affected.Neuroscience Bulletin+2Charcot-Marie-Tooth Association+2

This condition follows an autosomal recessive pattern. This means a person becomes ill only when they receive one faulty copy of the responsible gene from each parent. Parents usually have no symptoms themselves because they carry only one faulty copy and one working copy.NCBI+2Monarch Initiative+2

Other Names and Types

Autosomal recessive intermediate Charcot-Marie-Tooth disease type C is known by several other names in medical databases and genetic reports. These different names all refer to the same disorder:

• Charcot-Marie-Tooth disease recessive intermediate C

• Charcot-Marie-Tooth disease, recessive intermediate type C

• Autosomal recessive intermediate Charcot-Marie-Tooth disease type C

• CMTRIC

• RI-CMT type C

• RI-CMTC

• PLEKHG5 Charcot-Marie-Tooth disease

• Charcot-Marie-Tooth disease caused by mutation in PLEKHG5 GARD Information Center+2Monarch Initiative+2

CMT itself is a large group of hereditary neuropathies. Doctors classify CMT by where the main nerve damage is and by inheritance pattern. Demyelinating forms mainly damage myelin (for example CMT1), axonal forms mainly damage the axon (for example CMT2), and intermediate forms show features of both on nerve conduction tests.Wikipedia+2Neuroscience Bulletin+2

Within intermediate CMT, there are autosomal recessive types A, B, C and D (RI-CMTA, RI-CMTB, RI-CMTC, RI-CMTD). Each type is linked to a different gene. CMTRIC is the subtype caused by changes in the PLEKHG5 gene, while the other subtypes are linked to genes such as GDAP1, KARS1 and COX6A1.Charcot-Marie-Tooth Association+2Neuroscience Bulletin+2

Causes and Risk Factors

1. Pathogenic variants in the PLEKHG5 gene
   The main direct cause of CMTRIC is harmful (“pathogenic”) changes in the PLEKHG5 gene, which provides instructions for a protein important in motor nerve cells. When both copies of this gene are faulty, peripheral nerves cannot work normally, leading to weakness and sensory loss.Institut de Myologie+3NCBI+3UniProt+3

2. Autosomal recessive inheritance from carrier parents
   In almost all families, each parent carries one faulty PLEKHG5 copy but is healthy. Their child becomes affected only if they inherit the faulty copy from both parents. This autosomal recessive pattern is well described in CMTRIC and explains why the disorder can appear “out of the blue” in a family.NCBI+2GARD Information Center+2

3. Homozygous PLEKHG5 mutations
   Some patients have the exact same mutation on both gene copies (homozygous mutation). This means the same error is present in both parental copies, giving a strong, consistent loss of normal PLEKHG5 function and producing the neuropathy.Institut de Myologie+2ScienceDirect+2

4. Compound heterozygous PLEKHG5 mutations
   Other patients carry two different harmful changes, one on each copy of PLEKHG5 (compound heterozygous). Even though the changes are different, each copy is still non-functional, so the overall effect in the nerves is similar to a homozygous mutation.Wiley Online Library+2Ma’ayan Lab+2

5. Loss of RhoGEF activity in motor neurons
   The PLEKHG5 protein acts as a Rho-specific guanine nucleotide exchange factor (RhoGEF) that helps control RhoA signaling, which is important for the shape and survival of nerve cells. Loss-of-function mutations disturb this signaling and make motor neurons more likely to degenerate.Wikipedia+2Springer+2

6. Disruption of NF-κB signaling and cell survival
   PLEKHG5 normally helps activate the NF-κB signaling pathway, which supports neuron survival. Studies show that some PLEKHG5 mutations reduce NF-κB activation, which can make nerve cells more fragile and easier to damage over time.ScienceDirect+2UCSC Genome Browser+2

7. Impaired autophagy of synaptic vesicles
   Experimental work suggests PLEKHG5 helps control autophagy of synaptic vesicles in motor neurons. Faulty autophagy means old or damaged cell parts are not cleared properly, which may contribute to the progressive nerve damage seen in CMTRIC.Nature+2Springer+2

8. Mixed demyelinating and axonal nerve damage
   Nerve biopsies in intermediate CMT, including CMTRIC, often show both myelin changes and axonal loss. Damage in both structures reduces the speed and strength of electrical signals, causing weakness, sensory loss and absent reflexes in the limbs.MalaCards+2MIPS+2

9. Length-dependent vulnerability of long nerves
   The longest nerves, especially those going from the spinal cord to the feet, are most affected. Because signals have to travel a long distance, any damage to axons or myelin is felt first in the feet and later in the hands, giving the classic “stocking-glove” pattern of CMT.Wikipedia+2Wikipedia+2

10. Muscle denervation and imbalance around the ankle and foot
    Long-term nerve damage leads to denervation of small foot muscles. Some muscles become weak while others remain relatively strong, pulling the foot into high arches and hammer toes. This imbalance is a key reason for the typical CMT foot deformities.PMC+2upload.orthobullets.com+2

11. Parental consanguinity (parents related by blood)
    In some reported families, parents are related (for example, cousins). When relatives have children together, they are more likely to carry the same rare mutation, which increases the chance that their child will inherit two faulty PLEKHG5 copies and develop CMTRIC.Institut de Myologie+2CAGS+2

12. Additional variants in other CMT-related genes (modifier effect)
    Research on hereditary neuropathies shows that extra changes in other nerve genes sometimes modify severity or age at onset, even when PLEKHG5 is the main disease gene. These “modifier” variants do not cause CMTRIC alone but may change how severe it becomes.Karger Publishers+2Neuroscience Bulletin+2

13. Coexisting diabetes causing extra nerve damage
    Diabetes can cause its own peripheral neuropathy through long-term high blood sugar. In a person who already has CMTRIC, poor diabetes control can add more nerve injury and make weakness, numbness and pain worse than expected from the genetic disease alone.Mayo Clinic+2Mayo Clinic+2

14. Vitamin B12 deficiency and other nutritional problems
    Low vitamin B12 and certain other vitamin shortages can damage peripheral nerves. While they do not cause CMTRIC by themselves, if a person with CMTRIC also has poor nutrition, the added neuropathy from vitamin deficiency can worsen symptoms and disability.PMC+2Cleveland Clinic+2

15. Alcohol misuse producing additional neuropathy
    Heavy, long-term alcohol use can produce alcoholic neuropathy by direct toxicity and by worsening nutrition. In someone with CMTRIC, this extra nerve damage may make weakness, pain and walking problems much more severe.Mayo Clinic+2MedlinePlus+2

16. Endocrine disorders such as hypothyroidism
    Hypothyroidism and some other hormonal problems are recognized causes of peripheral neuropathy. If they occur together with CMTRIC, they may add to nerve damage and increase fatigue, numbness and muscle weakness.Mayo Clinic+2Wikipedia+2

17. Exposure to neurotoxic medications or toxins
    Certain chemotherapy drugs, some antibiotics and heavy metals can injure peripheral nerves. In a person whose nerves are already vulnerable because of PLEKHG5 mutations, these exposures may result in faster progression or suddenly worse symptoms.PMC+2Wikipedia+2

18. Previous physical injury to peripheral nerves
    Trauma, repeated pressure or surgery around major nerves can cause additional local neuropathy. For people with CMTRIC, this may cause sudden worsening in one limb or make asymmetry more obvious, although the underlying genetic disease remains the main cause.Wikipedia+2NCBI+2

19. Chronic systemic illnesses (kidney, liver or autoimmune disease)
    Some chronic conditions such as kidney failure, liver disease and autoimmune disorders can damage nerves. If a person with CMTRIC also has one of these illnesses, the combined effect can increase pain, numbness and functional loss.Mayo Clinic+2Wikipedia+2

20. Ageing of the nervous system
    Even in healthy people, nerve repair becomes slower with age. In someone with a lifelong genetic neuropathy like CMTRIC, natural ageing may bring a gradual worsening of walking, balance and hand function as the years pass.Wikipedia+2Muscular Dystrophy Association+2

Symptoms and Clinical Features

1. Progressive weakness in the feet and lower legs
   One of the earliest and most constant symptoms is slowly worsening weakness of the small muscles in the feet and lower legs. People may notice difficulty lifting the front of the foot, climbing stairs, or keeping up with others when walking.Muscular Dystrophy Association+3GARD Information Center+3MalaCards+3

2. Muscle wasting of the calves and feet
   Over time, the muscles that are not properly supplied by the damaged nerves become thin and wasted, especially in the lower legs and feet. The calves can look “inverted champagne bottle” shaped, with bony ankles and prominent tendons.CAGS+2Monarch Initiative+2

3. Foot drop and high-stepping gait
   Weakness of the muscles that lift the foot leads to foot drop. To avoid catching the toes on the ground, people may lift their knees higher than normal when walking, giving a “high-stepping” or “steppage” gait that is typical of CMT.Wikipedia+2physio-pedia.com+2

4. Foot deformities such as pes cavus and hammer toes
   Many individuals develop high-arched feet (pes cavus) and curled toes (hammer toes) due to long-standing muscle imbalance. These deformities can make balance harder, increase the risk of ankle sprains and cause pressure sores or calluses.Medscape eMedicine+3GARD Information Center+3PMC+3

5. Unsteady gait and poor balance
   Weak muscles, loss of joint position sense and foot deformities all contribute to unsteady walking. Patients may feel wobbly on uneven ground, have trouble walking in the dark and often widen their stance to feel more stable.Orpha+2Muscular Dystrophy Association+2

6. Frequent tripping and falls
   Because of foot drop and poor proprioception (position sense), patients may trip on small obstacles or their own toes and may fall, especially when tired or walking quickly. These falls can lead to injuries and may limit confidence in walking.Wikipedia+2WikiDoc+2

7. Distal sensory loss in the feet
   Loss of feeling usually begins in the toes and soles. People may notice numbness, reduced ability to feel vibration, or difficulty sensing hot and cold. Over time, this sensory loss can rise up the legs in a “stocking” pattern.WikiDoc+3GARD Information Center+3MalaCards+3

8. Reduced or absent tendon reflexes
   Deep tendon reflexes, especially the ankle jerk, are often reduced or absent because the reflex arc is interrupted by the damaged peripheral nerve. This finding is common in CMT and is an important clue on neurological examination.nhs.uk+3GARD Information Center+3WikiDoc+3

9. Weakness in the hands and distal upper limbs
   As the disease progresses, similar weakness and wasting can appear in the small muscles of the hands and forearms. Tasks that need fine finger control, such as buttoning clothes, writing or using tools, may become slow or difficult.MalaCards+2Wikipedia+2

10. Loss of fine touch and vibration in the hands
    Distal sensory loss can also affect the hands, leading to numbness or tingling in the fingers. People may drop objects, have difficulty feeling small items and be less aware of injuries such as cuts or burns on the fingers.MalaCards+2Muscular Dystrophy Association+2

11. Muscle cramps and leg pain
    Some patients experience cramps, aching or burning pain in the feet and legs, especially after walking or at night. This neuropathic pain is caused by abnormal nerve firing and can add to sleep problems and fatigue.PMC+2GARD Information Center+2

12. Fatigue and reduced walking endurance
    Because walking requires more effort when muscles are weak and balance is poor, many people with CMTRIC tire easily. They may need frequent rests, avoid long distances and struggle with activities that require prolonged standing.Wikipedia+2Muscular Dystrophy Association+2

13. Difficulty running and participating in sports
    Problems with speed, coordination and ankle stability often make running, jumping and competitive sports hard or impossible, especially from adolescence onwards. Children may be seen as “clumsy” or less athletic than their peers.GARD Information Center+2Muscular Dystrophy Association+2

14. Occasional spinal or posture changes
    Some people with CMT develop spinal curvature or postural changes due to long-standing muscle weakness and imbalance. Although not specific to CMTRIC, these changes can contribute to back pain and further affect balance.Wikipedia+2Medscape eMedicine+2

15. Emotional and social impact
    Living with a visible, progressive disability can lead to worry, sadness or loss of confidence, especially in teenagers and young adults. Fear of falling or embarrassment about walking can reduce social activity and quality of life.NMD Journal+2PMC+2

Diagnostic Tests

Physical Examination

1. General neurological examination
A neurologist begins with a full neurological exam, checking muscle bulk, strength, tone, reflexes, and sensation in all limbs. In CMTRIC, they usually find distal muscle wasting, weakness, reduced or absent reflexes and length-dependent sensory loss, especially in the lower limbs.NCBI+2WikiDoc+2

2. Gait and posture assessment
The doctor watches how the person stands and walks, looking for foot drop, high-stepping gait, ankle instability and difficulty walking on heels or toes. These signs are common in CMT and help distinguish neuropathic weakness from muscle or joint problems.physio-pedia.com+2Medscape eMedicine+2

3. Inspection of feet, legs and hands
Careful inspection may show high arches, hammer toes, calluses, ankle deformity and “inverted champagne bottle” calves, plus guttering between hand bones from intrinsic muscle wasting. These visible changes strongly support a diagnosis of hereditary neuropathy.LearnHaem | Haematology Made Simple+3PMC+3upload.orthobullets.com+3

4. Detailed sensory testing
The neurologist tests light touch, pinprick, vibration and position sense using simple tools such as cotton wool, a pin and a tuning fork. In CMTRIC, sensation is usually most reduced in the feet and ankles and may later be affected in the hands.Wikipedia+3GARD Information Center+3WikiDoc+3

Manual and Functional Tests

5. Manual muscle testing (MMT)
The doctor checks the strength of key muscles by asking the patient to push or pull against resistance with the feet, ankles, knees, hands and fingers. Distal muscles, like ankle dorsiflexors and toe extensors, are typically weaker than proximal muscles in CMTRIC.NCBI+2LearnHaem | Haematology Made Simple+2

6. Heel-toe walking and other functional gait tests
Simple walking tests, such as walking on heels, toes, and in a straight line, help show subtle weakness and balance problems. In CMT, heel walking is often difficult due to foot-drop, and patients may wobble or need support when asked to walk in challenging ways.Muscular Dystrophy Association+2physio-pedia.com+2

7. Balance tests (for example, Romberg test)
In the Romberg test, the patient stands with feet together, first with eyes open and then closed. Increased swaying or loss of balance with eyes closed suggests sensory ataxia from impaired joint position sense, which is common in length-dependent neuropathies like CMT.NCBI+2Wikipedia+2

8. Disability scales such as the CMT Neuropathy Score (CMTNS)
The CMTNS is a validated scoring system that combines symptoms, signs and nerve test results to measure disease severity and progression. It helps clinicians follow CMTRIC over time and compare disability across studies and clinical trials.PLOS+3Clinical Outcome Measures+3PMC+3

Laboratory and Pathological Studies

9. Basic blood tests to exclude other neuropathy causes
Although CMTRIC is genetic, doctors usually order tests such as fasting glucose, vitamin B12, thyroid function and kidney and liver tests. These help rule out other treatable causes of neuropathy that could exist alongside CMTRIC and worsen symptoms.Mayo Clinic+2PMC+2

10. Targeted genetic testing for PLEKHG5
Once clinical suspicion is high, genetic testing is essential. A targeted test can look specifically for known pathogenic variants in PLEKHG5 that are linked to CMTRIC. Finding two disease-causing variants (one on each allele) confirms the molecular diagnosis.HNL Lab Medicine+3NCBI+3UniProt+3

11. Multigene next-generation sequencing (NGS) CMT panels
In practice, many centers use NGS panels that test dozens of CMT-related genes at once, including PLEKHG5. This approach is efficient because over 100 genes can cause CMT, and panels have shown high diagnostic yield for intermediate and recessive forms.Karger Publishers+2ARUP Consult+2

12. Nerve (sural) biopsy in selected cases
A small sample of a sensory nerve (often the sural nerve) can be examined under the microscope. In intermediate CMT, biopsy may show both demyelination and axonal loss, supporting the diagnosis when genetic results are unclear, though biopsy is now used less often.MalaCards+2MIPS+2

Electrodiagnostic Studies

13. Motor nerve conduction studies (NCS)
Motor NCS measure the speed and size of electrical signals along motor nerves. In CMTRIC, conduction velocities are in an “intermediate” range (between typical demyelinating and axonal CMT), and response sizes may be reduced, reflecting mixed nerve damage.Neuroscience Bulletin+2Mayo Clinic+2

14. Sensory nerve conduction studies
Sensory NCS assess the function of sensory fibers. In CMTRIC, sensory responses, especially from nerves in the legs, are often reduced or absent, matching the distal sensory loss reported by patients. This pattern supports a length-dependent hereditary neuropathy.WikiDoc+3MalaCards+3MIPS+3

15. Electromyography (EMG)
EMG uses a small needle electrode to record electrical activity from muscles. In CMTRIC, EMG typically shows signs of chronic denervation and reinnervation, such as large motor units and reduced recruitment, confirming that weakness is due to neuropathy, not muscle disease.NCBI+2ScienceDirect+2

16. F-wave and late response studies
F-waves and other late responses look at conduction along the full length of motor nerves. Abnormal or delayed responses can reveal more proximal involvement and help distinguish CMTRIC from other neuropathies with similar symptoms but different electrophysiologic patterns.Neuroscience Bulletin+2NCBI+2

Imaging Studies

17. Foot and ankle X-rays
Plain X-rays of the feet and ankles show bone alignment and help document pes cavus, hammer toes, heel varus and other deformities. This information is useful when planning orthotics or surgery and for monitoring structural changes over time.upload.orthobullets.com+2PMC+2

18. Spinal X-ray or MRI for skeletal changes
If posture problems or suspected spinal curvature exist, imaging of the spine can show scoliosis or other deformities related to muscle weakness. Although not specific to CMTRIC, these findings can guide physical therapy and orthopedic management.Medscape eMedicine+2NCBI+2

19. Muscle MRI of the lower legs
Muscle MRI can show patterns of fatty replacement and atrophy in specific muscle groups, often in a characteristic “distal more than proximal” pattern in CMT. These patterns can support the diagnosis and sometimes help distinguish different inherited neuropathies.Institut de Myologie+2Karger Publishers+2

20. Peripheral nerve ultrasound or MR neurography
High-resolution ultrasound and MR neurography can visualize nerve size and structure. In some forms of CMT, nerves are enlarged. While data in CMTRIC are limited, these tools are increasingly used to complement nerve conduction studies and better understand peripheral nerve pathology.NCBI+2ScienceDirect+2

Non-pharmacological treatments

1. Individualized physical therapy
Physical therapy is one of the most important non-drug treatments for autosomal recessive intermediate CMT type C. A trained therapist designs simple strengthening and stretching exercises to keep muscles working as long as possible and to maintain joint range of movement. Gentle, regular exercise helps delay contractures (stiff joints), improves balance and reduces fatigue in daily life. Programs often include low-impact activities such as cycling or swimming, which put less stress on weak ankles while still training the heart and lungs.Muscular Dystrophy Association+2ScienceDirect+2

2. Ankle-foot orthoses (AFOs)
Ankle-foot orthoses are light braces worn inside or around the shoes to hold the ankle at a safe angle and prevent the front of the foot from dropping during walking. In CMT, AFOs can reduce tripping, improve walking speed and make walking less tiring. Modern carbon-fiber AFOs are thin and can fit into many types of shoes. They must be carefully fitted and checked regularly so they do not rub the skin, because many people with CMT have reduced sensation and may not feel early pressure sores.Charcot-Marie-Tooth Association+2www.slideshare.net+2

3. Custom footwear and insoles
Custom shoes and soft insoles help correct or support high-arched feet and hammer toes. Shoe adaptations can include extra depth for clawed toes, a firm heel counter for stability and rocker soles that help the foot roll forward when ankle movement is limited. Good footwear spreads pressure evenly under the foot, helps protect numb skin from ulcers and can greatly improve comfort for long standing or walking. Podiatrists and orthotists often work together to design the best footwear plan.PMC+2OrthoInfo+2

4. Occupational therapy for daily activities
Occupational therapists focus on making day-to-day tasks easier and safer. They may teach simple energy-saving techniques, suggest hand splints for grip weakness, and recommend devices such as built-up pens, special cutlery, button hooks or zipper pulls. For a student or worker with autosomal recessive intermediate CMT type C, occupational therapy can help with computer use, writing, and safe transfers, and can support school or workplace adjustments so the person can stay active and independent.Muscular Dystrophy Association+1

5. Balance and gait training
Because distal muscle weakness and sensory loss make balance difficult, structured balance training can reduce falls. Simple exercises may include standing on different surfaces, turning safely, and stepping in different directions while holding onto a rail or therapist’s arm. Treadmill training with or without body-weight support can help improve walking pattern. These programs are adjusted carefully so the person feels challenged but not unsafe or overly tired.ScienceDirect+1

6. Stretching to prevent contractures
Regular stretching of calves, hamstrings and muscles under the foot helps prevent joints from stiffening into fixed positions, which can make walking and brace fitting more difficult. Stretches are usually gentle and held for 20–30 seconds, repeated several times a day. Families can be taught to help children stretch safely. Keeping joints flexible also reduces pain related to tight muscles and abnormal walking patterns.ScienceDirect+1

7. Low-impact aerobic exercise
Aerobic exercise such as swimming, water walking, cycling or arm-ergometer training can improve overall fitness and reduce fatigue without overloading weak foot and ankle muscles. Exercise plans usually start slowly and increase gradually, paying attention to pain and tiredness. Good aerobic fitness supports heart and lung health, helps with weight control and may improve mood and sleep in people living with chronic nerve disease.Muscular Dystrophy Association+1

8. Strength training with supervision
Targeted strength training of less-affected muscles around the hips and core can improve stability, even if the distal muscles in the feet and hands cannot gain much strength. Light weights or resistance bands are used, and exercise is stopped if it increases nerve pain or severe fatigue. The goal is not bodybuilding but better function for standing, transfers and walking.ScienceDirect+1

9. Hand therapy and fine-motor training
As the disease progresses, some people develop hand weakness and loss of fine movements. Hand therapy offers specific exercises and strategies to improve grip, pinch, and finger coordination. Therapists may recommend splints that position the wrist and fingers to allow the remaining muscles to work more efficiently, making writing, phone use and self-care tasks easier.MalaCards+1

10. Podiatry and skin care
Because feeling in the feet is often reduced, people may not notice small injuries from shoes or walking. Regular visits to a podiatrist for nail care, callus removal and skin checks are important. Education on daily foot inspections, drying carefully between the toes, and avoiding walking barefoot helps prevent ulcers and infections, especially when there is deformity or pressure from braces.PMC+2OrthoInfo+2

11. Fall-prevention home modifications
Simple changes at home can reduce fall risk: removing loose rugs, improving lighting, adding grab bars in bathrooms, and using rails on stairs. Raised toilet seats, shower chairs and non-slip mats also help. These changes are especially helpful when ankle weakness and sensory loss make sudden changes in surface dangerous.Muscular Dystrophy Association+1

12. Psychological support and counseling
Living with a rare lifelong nerve disease can be emotionally difficult. Counseling or peer-support groups give people and families a safe place to talk about fear, sadness or frustration. Cognitive-behavioral strategies can help manage chronic pain, fatigue and anxiety. Feeling understood and supported often improves coping and quality of life even when physical symptoms do not change.Muscular Dystrophy Association+1

13. Genetic counseling for family planning
Because the disease is autosomal recessive, each child of two carriers has a 25% chance of being affected. Genetic counselors explain this in simple terms, discuss carrier testing for family members and talk about options in future pregnancies. They also help families understand that carriers are usually healthy but can pass the gene change on.NCBI+2Monarch Initiative+2

14. Education and self-management training
Clear, reliable information about autosomal recessive intermediate CMT type C helps people take part in their own care. Teaching includes how to pace daily activities, how to choose safe exercises, how to check skin and how to talk to doctors about new symptoms. Patient organizations for CMT provide booklets, videos and online seminars that many families find helpful.Muscular Dystrophy Association+2Charcot-Marie-Tooth Association+2

15. School and workplace accommodations
Children may need extra time between classes, permission to use lifts, or modified physical education. Adults may need ergonomic chairs, footrests, voice-to-text software or flexible hours. These adjustments protect health, reduce fatigue and allow people with CMT to meet their academic or work goals.Muscular Dystrophy Association+1

16. Weight management and nutrition counseling
Excess body weight makes walking and standing harder and increases strain on weak ankles and deformed feet. A dietitian can help design a balanced eating plan that supports healthy weight and provides enough protein, vitamins and minerals for muscle and nerve health. This is especially important when reduced mobility makes weight gain more likely.Frontiers+1

17. Pain coping strategies and relaxation techniques
Chronic neuropathic pain and muscle aches are common in CMT. Simple techniques such as paced breathing, muscle relaxation, mindfulness and distraction can reduce the impact of pain on daily life. When combined with appropriate medications, these skills help some people use lower drug doses and feel more in control.Springer+2Charcot-Marie-Tooth Association+2

18. Use of canes, crutches or walkers
Mobility aids can increase safety and independence when balance and ankle strength worsen. A physical therapist helps choose the right device and teaches correct use to avoid falls and shoulder strain. Using a cane or walker is not “giving up”; it is a way to stay active with less fear of falling.OrthoInfo+1

19. Community-based rehabilitation and sports
Adaptive sports (such as wheelchair basketball, seated yoga or adaptive swimming) and community exercise groups provide both physical and social benefits. These activities keep people moving, fight loneliness and improve mood. Programs focused on people with neuromuscular disease often understand CMT-specific limitations and can adapt exercises safely.Muscular Dystrophy Association+1

20. Regular multidisciplinary clinic reviews
Best practice for CMT is follow-up in a multidisciplinary clinic that includes neurology, rehabilitation, orthopedics, podiatry and genetics. Regular review allows early detection of new problems such as severe deformity, scoliosis or worsening pain and allows timely changes to braces, therapy or surgery plans.Muscular Dystrophy Association+2ScienceDirect+2

Drug treatments

Important note: There is no specific FDA-approved drug that cures autosomal recessive intermediate CMT type C. Drug treatment focuses on symptoms such as neuropathic pain, cramps, mood problems and sleep issues. Doses below are typical adult ranges from FDA labels or neuropathic-pain guidelines, not personal medical advice. Always ask a qualified doctor before starting or changing any medicine.Springer+2Muscular Dystrophy Association+2

1. Pregabalin (Lyrica) – gabapentinoid
Pregabalin reduces abnormal nerve firing and is FDA-approved for several types of neuropathic pain, including diabetic peripheral neuropathy and post-herpetic neuralgia. Typical adult dosing for neuropathic pain starts around 150 mg per day divided into two or three doses, and may increase up to 300–600 mg/day if tolerated. It can ease burning and shooting pain and improve sleep in people with CMT-related neuropathic pain, although this use is off-label. Common side effects include dizziness, sleepiness, weight gain and ankle swelling.Charcot-Marie-Tooth Association+3FDA Access Data+3FDA Access Data+3

2. Gabapentin (Neurontin) – gabapentinoid
Gabapentin is another anti-seizure drug widely used for neuropathic pain, including post-herpetic neuralgia, and often used off-label for other nerve pains. Adult dosing for neuropathic pain usually starts low (for example 300 mg at night) and slowly increases, sometimes up to 1800–3600 mg/day in divided doses, depending on kidney function and side effects. Gabapentin can reduce burning, tingling and allodynia (pain from light touch). Side effects include dizziness, drowsiness and unsteadiness, so doses must be increased slowly and monitored carefully.Charcot-Marie-Tooth Association+3FDA Access Data+3FDA Access Data+3

3. Duloxetine (Cymbalta) – SNRI antidepressant
Duloxetine is an antidepressant that also treats neuropathic pain, especially diabetic peripheral neuropathic pain and chronic musculoskeletal pain. Usual adult doses are 60–120 mg once daily. It acts on serotonin and norepinephrine in the brain and spinal cord to reduce pain signaling. For people with CMT who also have anxiety or depression, duloxetine may help both mood and nerve pain. Common side effects include nausea, dry mouth, sweating and sleep changes, and rare nitrosamine contamination issues have led to some product recalls, so label checks are important.Health+3FDA Access Data+3FDA Access Data+3

4. Amitriptyline – tricyclic antidepressant
Amitriptyline is an older antidepressant often used off-label in low doses for chronic neuropathic pain. A typical bedtime starting dose is 10–25 mg, gradually increased as needed and tolerated, often to 50–75 mg at night. It can reduce burning pain and help sleep but may cause dry mouth, constipation, weight gain and next-day drowsiness. At higher doses, it can affect the heart rhythm, so it should be used cautiously and generally avoided in people with significant heart disease.Charcot-Marie-Tooth Association+3NCBI+3FDA Access Data+3

5. Nortriptyline – tricyclic antidepressant
Nortriptyline works similarly to amitriptyline but is often a little better tolerated. For neuropathic pain, low doses such as 10–25 mg at night are used at first, increasing slowly to 50–100 mg if needed. It may improve sleep and chronic nerve pain in CMT, again off-label, but can still cause dry mouth, constipation and heart rhythm changes in some people, so monitoring is important.Springer+1

6. Venlafaxine – SNRI antidepressant
Venlafaxine acts on serotonin and norepinephrine and can help some people with neuropathic pain as well as depression or anxiety. Extended-release forms are often started at 37.5–75 mg daily and increased as needed. It may improve overall pain and emotional coping, but can raise blood pressure, cause nausea or insomnia, and must be tapered slowly to avoid withdrawal symptoms.Springer+1

7. Topical lidocaine 5% patches
Lidocaine patches are applied directly to areas of superficial burning pain, such as the top of the foot. They numb the skin and nearby small nerves without affecting the whole body. Patches are typically worn for up to 12 hours within a 24-hour period. They are especially useful when pain is localized and may have fewer systemic side effects than oral medicines.Springer+1

8. Topical capsaicin (low- or high-concentration)
Capsaicin creams or patches, made from chili pepper extract, deplete substance P and reduce pain signal transmission in small nerve fibers. Low-strength creams are applied several times daily; high-strength patches are applied under medical supervision. People often feel burning when treatment begins, which may improve later. Capsaicin is more suitable for localized neuropathic pain areas and should be used carefully on skin with reduced feeling to avoid unnoticed burns.Springer+1

9. Simple pain relievers (paracetamol / acetaminophen)
For mild muscle and joint aches related to abnormal walking, paracetamol (acetaminophen) can be used in short courses. Typical adult maximum doses are up to 3–4 g per day, but lower limits are safer, especially in people with liver disease. It does not treat neuropathic pain directly but may help background musculoskeletal discomfort when combined with other measures.Muscular Dystrophy Association+1

10. Non-steroidal anti-inflammatory drugs (NSAIDs)
NSAIDs such as ibuprofen or naproxen reduce inflammation and can help with joint pain from deformity or overuse but are less effective for pure nerve pain. They must be used carefully because of possible stomach, kidney and cardiovascular side effects, especially at high doses or for long periods. They are best taken with food and only when clearly needed.Muscular Dystrophy Association+1

11. Muscle relaxants for cramps (e.g., baclofen)
Some people with CMT experience troublesome leg cramps or spasticity. Baclofen acts on receptors in the spinal cord to reduce muscle overactivity. Low doses (for example 5–10 mg three times daily in adults) may be used and slowly adjusted. It can cause drowsiness and dizziness, and should not be stopped suddenly to avoid withdrawal symptoms.ScienceDirect+1

12. Short-term benzodiazepines (e.g., clonazepam)
Clonazepam may be used short-term for severe night cramps or anxiety that worsens pain. Doses are kept as low as possible because of risks of drowsiness, dependence, falls and breathing problems. These medicines are usually reserved for special situations and used under close supervision.Springer+1

13. Sleep aids (non-drug first)
When pain disrupts sleep, doctors first suggest sleep hygiene and pain control. If medicines are needed, options might include low-dose sedating antidepressants (such as amitriptyline) or other short-term agents. Good sleep improves daytime pain tolerance and mood, but sedative drugs must be used very carefully in people with balance problems to avoid night-time falls.Springer+2Muscular Dystrophy Association+2

14. Treatment of mood disorders (SSRIs, SNRIs)
Depression and anxiety can amplify pain and fatigue. Standard antidepressants such as SSRIs (for example sertraline) or SNRIs (duloxetine, venlafaxine) may be used when needed. They help mood and sometimes pain perception. Choice of medicine depends on individual history, other drugs and side-effect profile, and should always be made with a mental-health or primary-care clinician.Muscular Dystrophy Association+2Springer+2

15. Vitamin B12 replacement when deficient
Vitamin B12 deficiency can cause or worsen neuropathy. If blood tests show low B12, treatment may include injections or high-dose oral B12 (for example 1 mg/day) until levels normalize, then lower maintenance doses. Correcting deficiency can improve nerve symptoms and prevent further damage, but will not cure genetic CMT itself.Cureus+3PMC+3MDPI+3

16. Alpha-lipoic acid (ALA) – antioxidant (often classed as supplement, sometimes used like a drug)
ALA is an antioxidant that has been studied in diabetic neuropathy and may improve pain and nerve function by reducing oxidative stress and improving blood flow in small nerves. Doses in studies often range around 600 mg/day, sometimes higher under specialist supervision. Evidence is mixed but promising in diabetic neuropathy; in CMT it is experimental and should only be used under medical advice.PubMed+3PubMed+3MDPI+3

17. Management of co-existing conditions (e.g., diabetes, thyroid disease)
If a person with autosomal recessive intermediate CMT type C also has diabetes or thyroid problems, tight control of these conditions is crucial, because they can worsen neuropathy. Standard medicines for these diseases (insulin, oral diabetes drugs, thyroid hormone) indirectly protect the nerves by reducing extra damage from metabolic stress.MDPI+2PMC+2

18. Experimental disease-modifying therapy – PXT3003 (for CMT1A, not yet for this subtype)
PXT3003 is a combination of baclofen, naltrexone and sorbitol studied as a disease-modifying therapy for CMT1A. Phase III trials suggest improvement in functional scores and a good safety profile. It aims to lower over-expression of the PMP22 gene and improve myelination. However, it is not yet approved and has been studied mainly in CMT1A, not autosomal recessive intermediate CMT type C.ClinicalTrials+4PubMed+4Springer+4

19. Other experimental neuropathic-pain combinations
Some specialists may try combinations of gabapentinoids with SNRIs or tricyclics when one drug alone is not enough. For example, combining duloxetine and pregabalin has been studied in diabetic neuropathy with similar efficacy to monotherapy in some analyses. These combinations increase risks of side effects and must be tailored and monitored by experienced clinicians.PMC+2SciSpace+2

20. Supportive medications for associated problems
People with chronic pain and disability sometimes need medicines for constipation, reflux, or mood swings caused by other drugs. Using the smallest effective doses and reviewing medicines regularly reduces the overall burden of treatment. This “supportive pharmacology” is an important but often overlooked part of care in rare neuropathies.Muscular Dystrophy Association+1

Dietary molecular supplements

Evidence for supplements in autosomal recessive intermediate CMT type C is limited. Most data come from studies in other neuropathies. Always discuss supplements with a doctor to avoid interactions and overdose.

1. Vitamin B12 (methylcobalamin)
Vitamin B12 is essential for myelin formation and DNA synthesis in nerve cells. Deficiency can cause axonal neuropathy and spinal cord damage. When blood tests show low levels, replacement with injections or high-dose oral B12 (often around 1 mg/day initially) can improve nerve symptoms and prevent further damage. In people with CMT, correcting B12 deficiency may optimize whatever nerve function remains, even though it does not correct the underlying gene mutation.PubMed+3PMC+3ScienceDirect+3

2. B-complex vitamins (B1, B6, B9, B12 – cautious B6 dosing)
B vitamins support nerve energy metabolism and neurotransmitter production. Some formulations combine B1, B6 and B12 for neuropathy support. However, high-dose B6 has been linked to nerve damage, and regulators are restricting very high B6 dose supplements. Therefore, doses must stay within safe limits and be selected with medical advice. Used carefully, B-complex supplements may help nerve repair in people with borderline deficiencies.Diabetes Journals+2The Guardian+2

3. Alpha-lipoic acid (ALA)
ALA is a powerful antioxidant that recycles other antioxidants and improves blood flow in small nerves. Trials in diabetic neuropathy show that oral ALA around 600 mg/day can modestly reduce pain and improve symptoms, probably by reducing oxidative stress and inflammation in nerves. In CMT it is not disease-specific but may theoretically help general nerve health; its use should still be individualized and monitored.PubMed+3PubMed+3MDPI+3

4. Omega-3 fatty acids (EPA and DHA)
Omega-3 fats from fish oil or algae play a role in building nerve cell membranes and myelin. Experimental studies suggest they support remyelination and protect against nerve degeneration by reducing inflammation and oxidative stress and activating protective cell pathways. Typical supplemental doses range from about 1–2 g/day of combined EPA and DHA in adults, but the best dose for neuropathy is not yet clear. A diet rich in fatty fish, nuts and seeds also provides these fats naturally.duke-nus.edu.sg+3PMC+3Frontiers+3

5. Coenzyme Q10 (CoQ10)
CoQ10 is a key part of the mitochondrial electron transport chain and acts as an antioxidant in cell membranes. In mitochondrial diseases, supplementation (often 5–15 mg/kg/day) can improve muscle symptoms in some patients, and it has been widely used in neuromuscular conditions to support cellular energy. For CMT, evidence is limited but some clinicians consider CoQ10 as part of a general “mitochondrial support” strategy.MitoAction+3PubMed+3ScienceDirect+3

6. Vitamin D
Vitamin D influences bone health, immune function and possibly nerve health. Low vitamin D levels are common and are associated with increased pain and inflammation in several conditions. When blood tests show deficiency, supplements (often 800–2000 IU/day in adults, or as prescribed) can correct levels and support bone strength, which is important when gait is abnormal and falls are more likely.MDPI+1

7. Acetyl-L-carnitine
Acetyl-L-carnitine supports mitochondrial energy production and may help nerve regeneration. Studies in diabetic and chemotherapy-induced neuropathy suggest possible improvements in pain and nerve conduction, usually with doses around 1–3 g/day in divided doses. For CMT, its role is experimental. It should be used only under medical supervision, especially in people with seizure disorders.Health+1

8. N-acetyl cysteine (NAC)
NAC is a glutathione precursor and antioxidant. It may reduce oxidative stress and inflammation and has been explored as an add-on therapy in neuropathic pain. Typical doses in other conditions range from 600–1200 mg/day, but long-term safety for CMT patients is not well studied.Health+1

9. Magnesium
Magnesium is involved in nerve conduction and muscle relaxation. Low magnesium may contribute to cramps and muscle tension. Supplements (for example 200–400 mg/day in adults) may help some people sleep better and have fewer cramps, though evidence is modest. High doses can cause diarrhea and should be avoided in significant kidney disease.The Times of India+1

10. Choline-rich nutrients
Choline is a building block for cell membranes and acetylcholine, a key neurotransmitter. Adequate choline intake from diet (eggs, fish, legumes) supports brain and nerve health. Some people use choline or phosphatidylcholine supplements, but strong data for CMT are lacking, so food sources plus general balanced nutrition are usually preferred.The Times of India+1

Regenerative, immunity-related and stem-cell-linked drugs

At present, there are no approved immune-booster or stem cell drugs that cure autosomal recessive intermediate CMT type C. The ideas below describe research directions and supportive strategies rather than standard treatments.

1. Gene-targeted therapies
Researchers are developing gene therapies that deliver a healthy copy of a gene or silence a toxic gene using viral vectors such as AAV. In CMT1A, PXT3003 and other approaches aim to modify PMP22 expression and improve myelination. Similar strategies might one day be adapted for recessive intermediate CMT, but today they remain experimental and available only in clinical trials.Clinical Trials Register+4PubMed+4Springer+4

2. Neurotrophic factors and remyelination agents
Neurotrophic factors, such as neurotrophin-3, are proteins that support nerve survival, growth and myelination. Experimental drugs try to mimic or boost these signals to repair damaged myelin and axons. Animal studies and early human work in other neuropathies suggest potential benefit, but no such treatment is yet approved for any CMT subtype.ScienceDirect+2PMC+2

3. Experimental stem-cell therapies
Stem-cell approaches aim to provide cells that can support or replace damaged Schwann cells or neurons. Various types of stem cells (mesenchymal, neural progenitor, iPSC-derived) are being tested in preclinical models of neuropathy. For now, these treatments are experimental and should only be received in regulated clinical trials, not in commercial “stem-cell clinics” with unproven claims.ScienceDirect+2Wiley Online Library+2

4. Immune-modulating therapies (mainly for inflammatory neuropathies)
In acquired inflammatory neuropathies such as CIDP, immune-modulating treatments like IVIG, corticosteroids and plasma exchange can be effective. In genetic CMT, including autosomal recessive intermediate type C, the main problem is not the immune system, so these therapies are not standard. They might only be considered if there is clear evidence of an overlapping inflammatory neuropathy.ScienceDirect+1

5. General immune health support
General steps that support immune health – vaccinations, good sleep, balanced nutrition, physical activity and avoiding smoking – help the body cope with infections and surgery. While they do not cure the genetic neuropathy, they may reduce periods of worsening function triggered by illnesses or inactivity.Frontiers+2The Times of India+2

6. Future combination strategies
Future treatment strategies for CMT may combine disease-modifying drugs (such as gene therapy or small-molecule modulators) with rehabilitation, orthotics and symptom-control medicines. Clinical trials in CMT1A with PXT3003 show that disease-modifying approaches are feasible, encouraging further research that could one day extend to autosomal recessive intermediate CMT type C.ClinicalTrials+3PubMed+3Springer+3

Surgical treatments

1. Soft-tissue release for cavovarus foot
In early stages of severe high-arched (cavovarus) feet, surgeons may lengthen tight tendons and release tight tissues under the foot. This can restore a more normal foot position, improve shoe fit and reduce pain. It works best when done before the bones become very stiff and deformed.PMC+2OrthoInfo+2

2. Tendon transfer surgery
In tendon transfer procedures, a relatively strong tendon (for example, tibialis posterior) is moved to take over the role of a weak muscle (such as the one lifting the front of the foot). This can improve active foot lift, reduce foot drop and help walking even when nerve damage is fixed. The goal is to rebalance forces around the ankle and slow further deformity.PMC+1

3. Corrective osteotomy of foot bones
When deformities are rigid, surgeons may cut and realign foot bones (osteotomies) to create a plantigrade foot that rests flat on the ground. Plates, screws or pins hold the bones in the new position until they heal. This type of surgery aims to improve weight-bearing and reduce pain, making it easier to use braces and shoes.PMC+2OrthoInfo+2

4. Fusion (arthrodesis) of severely unstable joints
If ankle or hindfoot joints are severely unstable and painful, joint fusion may be considered. In this surgery, damaged joint surfaces are removed and the bones are fixed together so they grow into one solid bone. This sacrifices movement but can greatly improve stability and reduce pain, especially in late stages of CMT with severe deformity.PMC+2OrthoInfo+2

5. Spine and hand surgery for secondary problems
Some people with CMT develop scoliosis or severe hand deformities. In rare cases, spinal fusion or hand tendon releases may be needed to improve posture, breathing mechanics, or hand function. These surgeries are tailored to the individual and always balanced against the risks of anesthesia and recovery in a person with neuromuscular disease.Muscular Dystrophy Association+2OrthoInfo+2

Prevention and risk reduction

Because autosomal recessive intermediate CMT type C is genetic, we cannot prevent the basic gene change. However, we can prevent or reduce complications:

1. Avoid additional nerve toxins such as heavy alcohol use and certain chemotherapy drugs whenever safer alternatives exist, because they can worsen neuropathy.ScienceDirect+1

2. Treat vitamin deficiencies early, especially vitamin B12 and vitamin D, to avoid extra nerve damage and bone fragility.MDPI+2PubMed+2

3. Maintain a healthy body weight to reduce stress on weak feet and ankles and lower the risk of joint pain and falls.OrthoInfo+1

4. Use braces and footwear as recommended to prevent progressive deformity and skin ulcers instead of waiting until problems become severe.OrthoInfo+3Charcot-Marie-Tooth Association+3www.slideshare.net+3

5. Do regular safe exercise to keep muscles and joints moving and to protect heart and lung health.Muscular Dystrophy Association+2ScienceDirect+2

6. Check feet daily for blisters, redness or cuts, and get podiatry care early to stop small problems from turning into ulcers.PMC+2Pod NMD+2

7. Prevent falls by using mobility aids when needed and making home modifications (good lighting, handrails, non-slip surfaces).OrthoInfo+1

8. Keep vaccinations up to date so serious infections are less likely to cause long hospital stays and deconditioning.Muscular Dystrophy Association+1

9. Attend regular specialist follow-up so new issues like scoliosis, severe deformity or depression are caught early and treated promptly.Muscular Dystrophy Association+2ScienceDirect+2

10. Use genetic counseling for family planning to understand recurrence risks and carrier status, helping families make informed decisions.NCBI+2Monarch Initiative+2

When to see a doctor

People with known or suspected autosomal recessive intermediate CMT type C should see a doctor or neuromuscular specialist when they first notice symptoms such as frequent tripping, foot deformity, or loss of feeling in the feet. An urgent visit is needed if there is a sudden big change, such as rapidly worsening weakness, new severe pain, or problems with breathing or swallowing, because these may suggest another condition on top of CMT. Regular follow-up visits (often yearly or as advised) allow monitoring of walking, hand function, spine alignment and pain, and help coordinate therapy, orthotics, and possible surgery.NCBI+3Muscular Dystrophy Association+3ScienceDirect+3

What to eat and what to avoid

1. Eat a balanced diet rich in whole foods – fruits, vegetables, whole grains, lean proteins and healthy fats provide vitamins, minerals and antioxidants that support general nerve and muscle health.The Times of India+1

2. Include omega-3-rich foods such as fatty fish (salmon, sardines), flaxseeds and walnuts several times a week to support nerve cell membranes and myelin.PMC+2Frontiers+2

3. Ensure enough vitamin B12 and folate from foods like meat, fish, eggs and fortified cereals, especially for people who avoid animal products or take medicines that lower B12.PMC+2ScienceDirect+2

4. Keep vitamin D levels healthy with safe sunlight exposure, fortified foods or supplements when needed, to support bone and muscle function.MDPI+1

5. Stay well-hydrated, because dehydration can worsen fatigue and cramps.Frontiers+1

6. Avoid excessive alcohol, which is toxic to nerves and can significantly worsen neuropathy over time.ScienceDirect+1

7. Avoid very high-dose vitamin B6 supplements, which can themselves cause neuropathy when taken in large doses for long periods.The Guardian+1

8. Limit highly processed, high-sugar foods, because they promote weight gain and, if diabetes develops, can speed up nerve damage.Frontiers+2The Times of India+2

9. Choose foods rich in magnesium and antioxidants (leafy greens, nuts, seeds, berries), which may help muscle relaxation and reduce oxidative stress.The Times of India+1

10. Discuss any supplement plan with a clinician, so doses are appropriate and do not interact with other medicines or cause toxicity.Health+2MDPI+2

Frequently asked questions (FAQs)

1. Is autosomal recessive intermediate CMT type C curable?
No. At present there is no cure for autosomal recessive intermediate CMT type C. Treatment focuses on managing symptoms, supporting mobility and independence, and preventing complications through rehabilitation, orthotics, surgery when needed and pain management. Research into gene-targeted therapies and disease-modifying drugs is active, but nothing is yet approved for this subtype.Springer+3NCBI+3ScienceDirect+3

2. How is this subtype different from other types of CMT?
Intermediate CMT, including autosomal recessive type C, shows nerve conduction speeds between classic demyelinating (slow) and axonal (near-normal) forms, and biopsy may show mixed features. Inheritance is autosomal recessive, meaning both parents are usually carriers without symptoms. Signs and symptoms overlap with other CMT types, so genetic testing is often needed for a precise diagnosis.Muscular Dystrophy Association+3NCBI+3Monarch Initiative+3

3. Will everyone with this disease end up in a wheelchair?
Not necessarily. Severity and progression can vary widely, even within the same family. Many people remain able to walk with AFOs and good rehabilitation, although they may need mobility aids for longer distances or later in life. Early and ongoing non-pharmacological treatment helps preserve walking ability for as long as possible.Muscular Dystrophy Association+2ScienceDirect+2

4. Can exercise make the disease worse?
Appropriate, supervised exercise usually helps rather than harms. Over-strenuous or high-impact exercise can cause injuries or fatigue, but low-impact aerobic activity and carefully designed strengthening and stretching programs improve function, balance and overall health. A physical therapist experienced with neuromuscular disease should guide the plan.ScienceDirect+2OrthoInfo+2

5. Are pain medicines safe to take long-term?
Many neuropathic-pain medicines (gabapentinoids, SNRIs, tricyclics) can be used long-term, but they require regular review for side effects such as weight gain, drowsiness, mood changes or heart effects. Doses should be the lowest that gives useful relief. Strong opioids are generally avoided or used only short-term because of dependence and overdose risks.Charcot-Marie-Tooth Association+3FDA Access Data+3FDA Access Data+3

6. Do supplements like alpha-lipoic acid or CoQ10 really help?
In diabetic neuropathy and mitochondrial diseases, alpha-lipoic acid and CoQ10 have shown some benefits in trials, mainly by reducing oxidative stress and supporting mitochondrial function. For autosomal recessive intermediate CMT type C, direct evidence is lacking, so these supplements are considered experimental supportive options rather than proven treatments.ScienceDirect+4PubMed+4MDPI+4

7. Is it safe to try “stem-cell” clinics advertised online?
Most commercial stem-cell clinics offering cures for CMT operate outside standard scientific and regulatory frameworks. Their treatments are usually unproven and may be risky or very expensive. Stem-cell approaches for neuropathy should only be tried in properly monitored clinical trials approved by ethics boards and regulators.ScienceDirect+2Wiley Online Library+2

8. Can children with this disease play sports?
Many children with autosomal recessive intermediate CMT type C can take part in adapted sports and physical education. Activities that are low-impact and emphasize balance and fun, such as swimming or cycling, are usually best. Coaches and teachers should know about the child’s condition, need for braces and risk of ankle injuries or falls.Muscular Dystrophy Association+2OrthoInfo+2

9. How important are braces and orthotics really?
Braces and orthotics are central to treatment. They support weak muscles, improve foot position, reduce tripping and slow deformity progression. Many people find that once properly fitted AFOs are worn regularly, walking becomes easier and less tiring, and falls are less frequent.OrthoInfo+3Charcot-Marie-Tooth Association+3www.slideshare.net+3

10. Will surgery fix the problem permanently?
Surgery can correct deformities and improve function, but it does not stop the underlying genetic neuropathy. Over time, other parts of the foot or leg may still weaken. However, well-timed surgery combined with braces and therapy can give many years of better walking and less pain.PMC+2OrthoInfo+2

11. Should family members get genetic testing?
Genetic counseling can help relatives understand whether testing makes sense for them. Testing may be useful for siblings with mild symptoms or for adults planning a family, but each person has the right to choose whether or not to know their carrier status. Decisions depend on local laws, cost and personal values.NCBI+2Monarch Initiative+2

12. Can pregnancy make the disease worse?
Some women with CMT report temporary worsening of symptoms during pregnancy due to weight gain and fluid shifts, but long-term progression does not usually change dramatically. Pre-pregnancy counseling and close follow-up with neurology and obstetrics can help manage fatigue, balance and delivery planning safely.Muscular Dystrophy Association+2ScienceDirect+2

13. Are there international support organizations for this disease?
Yes. Organizations such as national CMT associations and neuromuscular disease foundations provide information, helplines, research updates and community events. They usually cover all CMT types, including rare subtypes like autosomal recessive intermediate CMT type C, and can help families connect with expert centers and trials.Muscular Dystrophy Association+2Charcot-Marie-Tooth Association+2

14. How often should someone with this disease have nerve tests?
Nerve conduction studies and EMG are important for diagnosis, but they are not always repeated regularly unless there is a major change in symptoms or participation in a clinical trial. Ongoing follow-up tends to focus more on clinical exam, function, and complications rather than frequent electrical tests.Muscular Dystrophy Association+2NCBI+2

15. What is the long-term outlook (prognosis)?
Autosomal recessive intermediate CMT type C usually progresses slowly over many years. Most people remain able to walk for a long time, especially with good rehab and orthotic support. Some may eventually need wheelchairs for longer distances, but life expectancy is generally near normal. Early diagnosis, regular follow-up and proactive management make a big difference in quality of life.Muscular Dystrophy Association+3NCBI+3MalaCards+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 24, 2025.